On 2 June 2026, EHI Commissioner Marcelino Pandin served as a speaker in a knowledge-sharing session on the legal aspects of merger and acquisition transactions at the United Nations Turin Campus in Turin, Italy. The session brought together legal experts, business leaders, and professionals to discuss the legal and regulatory challenges of cross-border investments, strategic partnerships, and corporate transactions. EHI’s participation reflected its commitment to strengthening legal preparedness and governance in supporting international collaboration within the biomolecular research and biotechnology sectors.
During the session, Commissioner Pandin shared EHI’s experience in preparing cross-border biomolecular research collaboration and investment initiatives, highlighting the legal considerations required to establish effective international partnerships. He emphasized the importance of harmonizing different legal systems, particularly common law and civil law, when drafting business agreements to ensure legal certainty, regulatory compliance, and smooth implementation across jurisdictions. The discussion also underscored the need for strong contractual frameworks, sound governance, and legal risk management to support innovation and responsible investment in the rapidly growing biomolecular industry. EHI believes that robust legal foundations are essential for fostering international scientific collaboration, attracting sustainable investment, and translating research into innovations that deliver long-term benefits for society.
